128 related articles for article (PubMed ID: 35908638)
1. Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia.
Plett C; Klauer LK; Amberger DC; Ugur S; Rabe A; Fischer Z; Deen D; Hirn-Lopez A; Gunsilius C; Werner JO; Schmohl J; Krämer D; Rank A; Schmid C; Schmetzer HM
Clin Immunol; 2022 Sep; 242():109083. PubMed ID: 35908638
[TBL] [Abstract][Full Text] [Related]
2. Generation of Leukaemia-Derived Dendritic Cells (DC
Schwepcke C; Klauer LK; Deen D; Amberger DC; Fischer Z; Doraneh-Gard F; Gunsilius C; Hirn-Lopez A; Kroell T; Tischer J; Weinmann M; Werner JO; Rank A; Schmid C; Schmetzer HM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955486
[TBL] [Abstract][Full Text] [Related]
3. Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro.
Klauer LK; Schutti O; Ugur S; Doraneh-Gard F; Amberger DC; Rogers N; Krämer D; Rank A; Schmid C; Eiz-Vesper B; Schmetzer HM
Transfus Med Hemother; 2022 Feb; 49(1):44-61. PubMed ID: 35221867
[TBL] [Abstract][Full Text] [Related]
4. Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
Hirn Lopez A; Deen D; Fischer Z; Rabe A; Ansprenger C; Stein K; Vogt V; Schick J; Kroell T; Kraemer D; Kolb HJ; Tischer J; Schmid C; Schmetzer H
J Immunother; 2019 Jun; 42(5):143-161. PubMed ID: 31090655
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture.
Unterfrauner M; Rejeski HA; Hartz A; Bohlscheid S; Baudrexler T; Feng X; Rackl E; Li L; Rank A; Filippini Velázquez G; Schmid C; Schmohl J; Bojko P; Schmetzer H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139264
[TBL] [Abstract][Full Text] [Related]
6. Leukemia derived dendritic cell (DC
Pepeldjiyska E; Li L; Gao J; Seidel CL; Blasi C; Özkaya E; Schmohl J; Kraemer D; Schmid C; Rank A; Schmetzer HM
Immunobiology; 2022 Jul; 227(4):152237. PubMed ID: 35749805
[TBL] [Abstract][Full Text] [Related]
7. PGE
Amberger DC; Doraneh-Gard F; Gunsilius C; Weinmann M; Möbius S; Kugler C; Rogers N; Böck C; Ködel U; Werner JO; Krämer D; Eiz-Vesper B; Rank A; Schmid C; Schmetzer HM
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533251
[TBL] [Abstract][Full Text] [Related]
8. Volatile Phases Derived from Serum, DC, or MLC Culture Supernatants to Deduce a VOC-Based Diagnostic Profiling Strategy for Leukemic Diseases.
Baudrexler T; Boeselt T; Li L; Bohlscheid S; Boas U; Schmid C; Rank A; Schmohl J; Koczulla R; Schmetzer HM
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371569
[TBL] [Abstract][Full Text] [Related]
9. Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes.
Rackl E; Li L; Klauer LK; Ugur S; Pepeldjiyska E; Seidel CL; Gunsilius C; Weinmann M; Doraneh-Gard F; Reiter N; Plett C; Amberger DC; Bojko P; Kraemer D; Schmohl J; Rank A; Schmid C; Schmetzer HM
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613907
[TBL] [Abstract][Full Text] [Related]
10. Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DC
Ansprenger C; Amberger DC; Schmetzer HM
Clin Immunol; 2020 Aug; 217():108467. PubMed ID: 32464186
[TBL] [Abstract][Full Text] [Related]
11. Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.
Merle M; Fischbacher D; Liepert A; Grabrucker C; Kroell T; Kremser A; Dreyssig J; Freudenreich M; Schuster F; Borkhardt A; Kraemer D; Koehne CH; Kolb HJ; Schmid C; Schmetzer HM
Immunobiology; 2021 May; 226(3):152088. PubMed ID: 33838552
[TBL] [Abstract][Full Text] [Related]
12. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
[TBL] [Abstract][Full Text] [Related]
14. Biological characteristics of CD7 positive acute myelogenous leukaemia.
Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
[TBL] [Abstract][Full Text] [Related]
15. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
[TBL] [Abstract][Full Text] [Related]
16. Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia.
Tokunaga Y; Miyamoto T; Okamura T; Eto T; Gondo H; Kamimura T; Okamura S; Niho Y
Br J Haematol; 1998 Sep; 102(5):1232-40. PubMed ID: 9753051
[TBL] [Abstract][Full Text] [Related]
17. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
Re F; Arpinati M; Testoni N; Ricci P; Terragna C; Preda P; Ruggeri D; Senese B; Chirumbolo G; Martelli V; Urbini B; Baccarani M; Tura S; Rondelli D
Exp Hematol; 2002 Feb; 30(2):126-34. PubMed ID: 11823047
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
[TBL] [Abstract][Full Text] [Related]
20. Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.
Amberger DC; Schmetzer HM
Transfus Med Hemother; 2020 Dec; 47(6):432-443. PubMed ID: 33442338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]